Clinical trial
Hydroxychloroquine for the Prevention of Recurrent Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial
NCT02648464 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hydroxychloroquine for the Prevention of Recurrent Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial
- Lead sponsor
- Helsinki University Central Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 1, 2016
- Completion date
- December 31, 2019
- Enrollment
- 125 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, antirheumatic agents, cardiovascular diseases, hydroxychloroquine, inflammation, myocardial infarction